Comparison of Distraction Methods for Pain Relief of Trigger Finger Injection
NCT ID: NCT03445780
Last Updated: 2020-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1
INTERVENTIONAL
2019-06-30
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Cortisone Injection and Splinting for Trigger Finger
NCT03156829
Trigger Finger Treatment
NCT03847935
Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting
NCT01886157
Using the Gate Control Theory of Pain to Decrease Pain During Trigger Finger Corticosteroid Injections
NCT06401473
Intrasynovial Digital Anesthesia in Trigger Finger
NCT06476977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First Group
Skin cooling with ethyl chloride spray will be used for 5 seconds prior to injection
Ethyl chloride spray
Skin cooling with ethyl chloride spray 5 seconds prior to injection
Second Group
The skin between the distal palmar crease and the palmo-digital crease and the palmo-digital crease will be pinched for 5 seconds prior to injection
Pinching
Skin between the distal palmar crease and the palmo digital crease will be pinched for 5 seconds prior to injection
Third Group
Skin cooling with ethyl chloride spray will be used for 5 seconds prior to injection as well as a second pinch to the skin between the distal palmar crease and the palmo digital crease
Ethyl chloride spray
Skin cooling with ethyl chloride spray 5 seconds prior to injection
Pinching
Skin between the distal palmar crease and the palmo digital crease will be pinched for 5 seconds prior to injection
Fourth Group
Subjects will sit behind a screen with a small opening large enough to introduce the injection hand. They will not see any of the procedure.
No Site of Procedure
Subjects will sit behind a screen with a small opening large enough to introduce the injected hand. They will not see any of the procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ethyl chloride spray
Skin cooling with ethyl chloride spray 5 seconds prior to injection
Pinching
Skin between the distal palmar crease and the palmo digital crease will be pinched for 5 seconds prior to injection
No Site of Procedure
Subjects will sit behind a screen with a small opening large enough to introduce the injected hand. They will not see any of the procedure
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eitan Melamed, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-01275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.